Trials that use: Wald / z-test
2,196 results
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).
- SEAMLESSIndependent statistical analysis of A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- SensoryFLOIndependent statistical analysis of Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SEQUOIA-HCMIndependent statistical analysis of Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM: primary endpoint results, effect estimate with confidence interval, sample-size…
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHIELDIndependent statistical analysis of Phase III Study in Refractory Behcet's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00995709).
- SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SINUS-52Independent statistical analysis of Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898454).
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SKYGGNIndependent statistical analysis of OCS-01 in Treating Inflammation and Pain in Post-cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130802).
- Skylight 2Independent statistical analysis of A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2: primary endpoint results, effect estimate with confidence…
- SKYSCRAPER-06Independent statistical analysis of SKYSCRAPER-06, evaluating tiragolumab plus atezolizumab and chemotherapy versus pembrolizumab plus chemotherapy in previously untreated advanced non-squamous NSCLC, with detailed interpretation of PFS, OS, response, quality-of-life, and safety analyses.
- SLEIndependent statistical analysis of A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689350).
- SOLEOIndependent statistical analysis of A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SOLO3Independent statistical analysis of Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received…
- SOM230Independent statistical analysis of Pasireotide LAR in Severe Polycystic Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670110).
- SOMNOSIndependent statistical analysis of Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01503164).
- SPARKIndependent statistical analysis of Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPARKIndependent statistical analysis of Kuvan® in Phenylketonuria Patients Less Than 4 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01376908).
- SPARK2Independent statistical analysis of Phase 2B Study Assessing Pain Relief After Replacement of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARTANIndependent statistical analysis of Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPIN-CHATIndependent statistical analysis of Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPIRE-HRIndependent statistical analysis of Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events: primary endpoint results, effect estimate with confidence interval, sample-size…
- SPIRITIndependent statistical analysis of Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244842).
- SPLDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPRING-2Independent statistical analysis of A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- STAGEIndependent statistical analysis of A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- STARDUSTIndependent statistical analysis of Liraglutide and Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04881110).
- STARTIndependent statistical analysis of Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02097641).
- STARTIndependent statistical analysis of Online Grammatical Reasoning Training for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661190).
- STATUREIndependent statistical analysis of Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- STEP-PAIndependent statistical analysis of Impact of Telephone Coaching on Physical Performance in a Physical Exercise Maintenance Program for Fallers Elderly Patients Living at Home: primary endpoint results, effect estimate with confidence interval,…
- STEP12Independent statistical analysis of A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range: primary endpoint results, effect estimate with confidence interval,…
- STOMPIndependent statistical analysis of Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- STRENGTHIndependent statistical analysis of Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- STRIDEIndependent statistical analysis of Implementing a Hospital-Based Walking Program (STRIDE): Function QUERI 2.0: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04868656).
- SUMMITIndependent statistical analysis of A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SUN1058Independent statistical analysis of A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone: primary endpoint results, effect estimate with confidence interval,…
- SuperShelfIndependent statistical analysis of A Multilevel Intervention in the Hunger Relief Network to Improve Diet Among Adults Experiencing Food Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SUPPORTIndependent statistical analysis of A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SURMOUNT-CNIndependent statistical analysis of A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURPASS-6Independent statistical analysis of A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin: primary endpoint results,…
- SURPHIndependent statistical analysis of A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SUSTAIN™ 5Independent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes: primary…
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SWIFT-1Independent statistical analysis of Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…